ATE434623T1 - Interleukin-15-antagonistisches peptid - Google Patents

Interleukin-15-antagonistisches peptid

Info

Publication number
ATE434623T1
ATE434623T1 AT05779505T AT05779505T ATE434623T1 AT E434623 T1 ATE434623 T1 AT E434623T1 AT 05779505 T AT05779505 T AT 05779505T AT 05779505 T AT05779505 T AT 05779505T AT E434623 T1 ATE434623 T1 AT E434623T1
Authority
AT
Austria
Prior art keywords
interleukin
antagonist peptide
antagonist
peptide
Prior art date
Application number
AT05779505T
Other languages
English (en)
Inventor
Savio Alicia Santos
Rico Ania Cabrales
Acosta Osvaldo Reyes
Perez Haydee Geronimo
Agueero Celia A Arrieta
Rodriguez Silvio Perea
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE434623T1 publication Critical patent/ATE434623T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05779505T 2004-09-17 2005-09-16 Interleukin-15-antagonistisches peptid ATE434623T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20040198A CU23472A1 (es) 2004-09-17 2004-09-17 Péptido antagonista de la interleucina-15
PCT/CU2005/000007 WO2006029578A1 (es) 2004-09-17 2005-09-16 Péptido antagonista de la interleucina-15

Publications (1)

Publication Number Publication Date
ATE434623T1 true ATE434623T1 (de) 2009-07-15

Family

ID=40262834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05779505T ATE434623T1 (de) 2004-09-17 2005-09-16 Interleukin-15-antagonistisches peptid

Country Status (18)

Country Link
US (1) US7736638B2 (de)
EP (1) EP1801119B1 (de)
JP (1) JP4750795B2 (de)
KR (1) KR101254113B1 (de)
CN (1) CN101120015B (de)
AR (1) AR051924A1 (de)
AT (1) ATE434623T1 (de)
AU (1) AU2005284529C1 (de)
BR (1) BRPI0515403B8 (de)
CA (1) CA2579798C (de)
CU (1) CU23472A1 (de)
DE (1) DE602005015131D1 (de)
ES (1) ES2328717T3 (de)
MX (1) MX2007002996A (de)
PT (1) PT1801119E (de)
RU (1) RU2396276C2 (de)
WO (1) WO2006029578A1 (de)
ZA (1) ZA200702128B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23716A1 (es) 2008-09-30 2011-10-05 Ct Ingenieria Genetica Biotech Péptido antagonista de la actividad de la interleucina-15
CN101831435B (zh) * 2010-05-10 2013-09-11 昆山贝瑞康生物科技有限公司 小鼠il-15亚型蛋白的制备及其应用
HRP20200470T1 (hr) 2011-01-18 2020-10-02 Bioniz, Llc Pripravci za modulaciju aktivnosti gama-c-citokina
PL404174A1 (pl) 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15
PL404138A1 (pl) 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
PL405505A1 (pl) 2013-09-30 2015-04-13 Warszawski Uniwersytet Medyczny Zastosowanie pochodnej kwasu diaminodikarboksylowego jako inhibitora aktywności biologicznej IL-15 I IL-2
PL405506A1 (pl) 2013-09-30 2015-04-13 Warszawski Uniwersytet Medyczny Zastosowanie pochodnej kwasu 7-aminocefalosporanowego jako inhibitora aktywności biologicznej IL-15 i IL-2
US9959384B2 (en) 2013-12-10 2018-05-01 Bioniz, Llc Methods of developing selective peptide antagonists
RU2689717C2 (ru) * 2014-01-08 2019-05-28 Шанхай Хэнжуй Фармасьютикал Ко., Лтд. Гетеродимерный белок il-15 и его применения
US10472403B2 (en) 2014-12-23 2019-11-12 Siemens Healthcare Diagnostics Inc. Proteolytic digestion of cardiac troponin I
KR102658190B1 (ko) * 2015-04-13 2024-04-17 리제너론 파마슈티칼스 인코포레이티드 인간화된 sirpa-il15 녹인 마우스 및 이의 이용 방법
CN119684428A (zh) 2015-10-09 2025-03-25 比奥尼斯治疗公司 调节γC-细胞因子活性
CN110214147A (zh) 2016-10-14 2019-09-06 Xencor股份有限公司 IL15/IL15Rα异源二聚体FC-融合蛋白
WO2018187499A1 (en) 2017-04-07 2018-10-11 Bioniz, Llc Stable modulators of gamma-c-cytokine activity
US11278505B2 (en) 2017-04-24 2022-03-22 University Of Massachusetts Diagnosis and treatment of vitiligo
KR101954214B1 (ko) 2017-05-23 2019-03-06 (주)케어젠 멜라닌 생성 촉진 활성을 나타내는 펩타이드 및 이의 용도
US11084863B2 (en) 2017-06-30 2021-08-10 Xencor, Inc. Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
CU24545B1 (es) 2017-12-29 2021-09-07 Ct Ingenieria Genetica Biotecnologia Péptido antagonista de la actividad de la interleucina-15
SG11202010163QA (en) 2018-04-18 2020-11-27 Xencor Inc Pd-1 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and pd-1 antigen binding domains and uses thereof
KR20210003813A (ko) 2018-04-18 2021-01-12 젠코어 인코포레이티드 IL-15/IL-15Rα Fc-융합 단백질 및 LAG-3 항원 결합 도메인을 함유하는 LAG-3 표적화 이종이량체 융합 단백질
CA3097625A1 (en) 2018-04-18 2019-10-24 Xencor, Inc. Il-15/il-15ra heterodimeric fc fusion proteins and uses thereof
US11505595B2 (en) 2018-04-18 2022-11-22 Xencor, Inc. TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains
AU2019359475A1 (en) 2018-10-12 2021-05-20 Xencor, Inc. PD-1 targeted IL-15/IL-15Ralpha Fc fusion proteins and uses in combination therapies thereof
CN113438961A (zh) 2018-12-20 2021-09-24 Xencor股份有限公司 含有IL-15/IL-15Rα和NKG2D抗原结合结构域的靶向异二聚体Fc融合蛋白
EP3976182A4 (de) 2019-05-03 2023-01-18 Bioniz, LLC Modulation der effekte der gamma-cytokin-signalisierung zur behandlung von alopezie und mit alopezie assoziierten störungen
TW202128757A (zh) 2019-10-11 2021-08-01 美商建南德克公司 具有改善之特性的 PD-1 標靶 IL-15/IL-15Rα FC 融合蛋白
KR20250044344A (ko) 2022-08-04 2025-03-31 노파르티스 파르마 아게 아토피 피부염의 치료에 유용한 il-15 저해제

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2261433A1 (en) * 1993-12-09 1995-06-10 Belinda Sanchez Ramirez Composition comprising autologous epidermal growth factor
PT772624E (pt) 1994-04-06 2001-03-30 Immunex Corp Interleucina-15
US6159937A (en) * 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
US5696234A (en) * 1994-08-01 1997-12-09 Schering Corporation Muteins of mammalian cytokine interleukin-13
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
DE69733610T2 (de) * 1996-04-26 2006-05-11 Beth Israel Deaconess Medical Center, Inc., Boston Interleukin-15 antagonisten
EP0849583A1 (de) * 1996-12-12 1998-06-24 European Community Hopkinson-Spaltstab-Testvorrichtung
DK1273304T4 (da) * 1997-02-21 2009-08-31 Amgen Inc Anvendelse af interleukin-15
GB9814892D0 (en) 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease
WO2001002003A1 (en) * 1999-07-06 2001-01-11 Bulfone Paus Silvia Method of treating psoriasis with il-15 antagonist
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
CU23093A1 (es) * 2002-10-09 2005-10-19 Ct Ingenieria Genetica Biotech Composición vacunal que comprende interleucina-15 (il-15)
EP1718670B1 (de) * 2004-02-27 2011-07-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Il-15-bindungsstelle für il-15-ralpha und spezifische il-15-mutanten mit wirkung als agonisten/antagonisten

Also Published As

Publication number Publication date
JP2008512994A (ja) 2008-05-01
AU2005284529B2 (en) 2010-11-25
AR051924A1 (es) 2007-02-21
CA2579798A1 (en) 2006-03-23
DE602005015131D1 (de) 2009-08-06
US7736638B2 (en) 2010-06-15
WO2006029578A1 (es) 2006-03-23
CA2579798C (en) 2012-08-21
BRPI0515403B1 (pt) 2019-03-26
CN101120015A (zh) 2008-02-06
KR101254113B1 (ko) 2013-04-15
JP4750795B2 (ja) 2011-08-17
AU2005284529A1 (en) 2006-03-23
US20090136511A1 (en) 2009-05-28
CN101120015B (zh) 2011-05-25
MX2007002996A (es) 2007-05-16
RU2396276C2 (ru) 2010-08-10
BRPI0515403A (pt) 2008-07-22
RU2007114288A (ru) 2008-10-27
BRPI0515403B8 (pt) 2021-05-25
PT1801119E (pt) 2009-09-21
ZA200702128B (en) 2008-08-27
CU23472A1 (es) 2009-12-17
EP1801119B1 (de) 2009-06-24
KR20070072876A (ko) 2007-07-06
ES2328717T3 (es) 2009-11-17
AU2005284529C1 (en) 2011-07-07
EP1801119A1 (de) 2007-06-27

Similar Documents

Publication Publication Date Title
ATE434623T1 (de) Interleukin-15-antagonistisches peptid
DE602005023727D1 (de) Plastiden transit peptide
DE602005023460D1 (de) Antimykotische polypeptide
EP2093287A4 (de) Igg bindendes peptid
EP1961761A4 (de) Neue peptidverbindung
DE502005007118D1 (de) Absaugvorrichtung
DE602005016771D1 (de) Taster
EP1735335A4 (de) Zellabtötende peptide
DK1776133T3 (da) Peptid-vasopressin-receptor-agonister
DE602005012757D1 (de) Antibakterielles Peptid
ATE397618T1 (de) Peptidcyclisierung
DK1809660T3 (da) Thymus-specifikt protein
EP1730180A4 (de) Gegen pilze wirkende peptide
DK1968623T3 (da) Bacteriocin-inducer-peptider
FI20050753L (fi) Uudet peptidit
DK1625148T3 (da) Peptidkompleks
DE602005014339D1 (de) Ür
EP1745070A4 (de) Peptidstabilisierung
FR2871811B1 (fr) Endofucanase recombinante
FI20075483A0 (fi) Uusi peptidi
DE502005007830D1 (de) Common-Rail-Injektor
DE502005007483D1 (de) Einspritzdüse
DE502005000548D1 (de) Common-Rail-Injektor
DK1761446T3 (da) Sugehoved
ATA12562004A (de) Einspritzdüse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties